Straits Times Index
3,219.00 -1.98 (-0.06%) S&P 500
3,981.70 +44.73 (+1.14%) Dow
32,297.75 +267.64 (+0.84%) Nasdaq
11,881.51 +211.55 (+1.81%) Bitcoin USD
27,392.22 -1,073.39 (-3.77%) CMC Crypto 200
598.80 +1.34 (+0.22%)
VRTX Apr 2023 340.000 put
| Previous close | 46.07 |
| Open | 46.00 |
| Bid | 35.70 |
| Ask | 42.10 |
| Strike | 340.00 |
| Expiry date | 2023-04-21 |
| Day's range | 46.00 - 46.10 |
| Contract range | N/A |
| Volume | |
| Open interest | N/A |
- Motley Fool
This Cathie Wood Stock Could Nearly Double, According to Wall Street
One stock that could ride the market rally is CRISPR Therapeutics (NASDAQ: CRSP). This biotech is seeking to develop breakthrough therapies for difficult-to-treat illnesses using gene editing, and the company's focus in this area earned it a prominent place in the Ark Genomic Revolution ETF, an exchange-traded fund overseen by Cathie Wood. Wood isn't the only one on Wall Street who likes CRISPR.
- Motley Fool
This Is My Highest-Conviction Stock to Own in 2023 and Beyond
While one could say the same about many biotech companies, Vertex has an advantage very few of its peers do: For CF patients, it's the only game in town. Vertex markets the only medicines that target the underlying causes of CF. In 2022, the company's revenue of $8.93 billion jumped by 18% year over year.
- Motley Fool
Got $3,000? 3 Growth Stocks to Double Up on Right Now
If you've got $3,000, here are three growth stocks to double up on right now. Amazon (NASDAQ: AMZN) has gotten off to a great start this year, with shares jumping around 16%. There are two main reasons behind Amazon's weak stock performance.
